Document Detail

[Psychiatric side effects of deep brain stimulation in Parkinson's disease].
MedLine Citation:
PMID:  22161166     Owner:  NLM     Status:  In-Data-Review    
Since the 1990 s deep brain stimulation (DBS) has provided an effective tool for the treatment of Parkinson's disease. About fifty thousand Parkinson patients have been treated by DBS so far. Although a relatively safe intervention, there are still some considerable side effects, psychiatric and non-psychiatric. We conducted a structured search using PubMed and included publications from 1999 to February 2011 to provide an overview of the current data concerning psychiatric side effects of DBS in Parkinson's disease. There was a tremendous variety and inconsistency concerning methods and results of the studies we included. However, it became apparent that postoperatively increased attention should be paid concerning a potentially increased suicidality and affective alterations (particularly manic states). We suggest frequent pre- and postoperative evaluations of Parkinson patients treated with DBS.
T Skuban; J Flohrer; J Klosterkötter; J Kuhn
Publication Detail:
Type:  English Abstract; Journal Article     Date:  2011-12-09
Journal Detail:
Title:  Fortschritte der Neurologie-Psychiatrie     Volume:  79     ISSN:  1439-3522     ISO Abbreviation:  Fortschr Neurol Psychiatr     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8103137     Medline TA:  Fortschr Neurol Psychiatr     Country:  Germany    
Other Details:
Languages:  ger     Pagination:  703-10     Citation Subset:  IM    
Copyright Information:
© Georg Thieme Verlag KG Stuttgart · New York.
Vernacular Title:
Psychiatrische Nebenwirkungen der Tiefen Hirnstimulation bei idiopathischem Parkinsonsyndrom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhibition of microRNA-17 Improves Lung and Heart Function in Experimental Pulmonary Hypertension.
Next Document:  [Neurobiology, Clinical Characteristics and Therapy in Tourette's Syndrome].